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The cytoplasmic repressor Keap1 regulates the function of transcription factor
Nrf2 which plays critical roles in oxidative and xenobiotic stresses. The Neh2
domain of Nrf2 interacts with Keap1 at the bottom region of the Kelch/
 -propeller domain which is formed by double-glycine repeat and C-terminal
region domains (Keap1-DC). The structure of Keap1-DC complexed with an
Nrf2 peptide containing a conserved DLG motif has been determined at 1.9 A ˚
resolution. The Keap1-bound DLG peptide possesses a hairpin conformation,
and it binds to the Keap1 protein at the bottom region of the  -propeller
domain. The intermolecular interaction occurs through their complementary
electrostatic interactions. Comparison of the present structure with the recently
reported Keap1-DC complex structure suggests that the DLG and ETGE motifs
of Neh2 in Nrf2 bind to Keap1 in a similar manner but with different binding
potencies.
Keywords: oxidative stress; Nrf2 transcription factor; Keap1; b-propeller domain; structure
of the complex.
1. Introduction
Higher animals have developed elaborate defense mechanisms to
counteract the damage that can be provoked by electrophiles and
reactive oxygen species (ROS) [see the review by Kobayashi &
Yamamoto (2006), and references therein]. Reactive molecules, such
as reactive oxygen species, electrophilic chemicals and heavy metals,
damage biological macromolecules and impair normal cellular func-
tions. Oxidative and xenobiotic stresses are known to cause diverged
pathological processes, including cancer, cardiovascular disease,
diabetes and neurodegeneration. A battery of genes encoding
detoxifying and anti-oxidative stress enzymes/proteins is coordinately
induced following exposure to electrophiles and ROS.
Nrf2 is the transcription factor for cytoprotective enzymes that
counteract oxidative and electrophilic attacks (Itoh et al., 1997). The
cellular concentration of Nrf2 remains low in homeostatic/unstressed
conditions, modulated by Keap1 (Kelch-like ECH associated protein
1) and proteasomal degradation (Itoh et al., 2004). Nrf2 contains a
conserved N-terminal regulatory domain termed Neh2, two trans-
activation domains, and a C-terminal bZIP domain.
The Keap1 protein is the direct binding partner of Nrf2 and is the
major negative regulator of cytoprotective gene expression (Itoh et
al., 1999). Keap1 possesses four characteristic domains: the BTB
domain, the intervening region (IVR); the double glycine repeat or
kelch repeat (DGR) and the C-terminal region (CTR). The BTB
domain, like its other structural homologs (Stogios et al., 2005), is
believed to serve in dimerization of Keap1 in the cytoplasm (Zipper
& Mulcahy, 2002).
Keap1 represses Nrf2 transcription functions and targets Nrf2
for ubiquitin-dependent degradation, under unstressed conditions
(Wakabayashi et al., 2003; Zhang & Hannink, 2003; Motohashi &
Yamamoto, 2004), by associating with the Neh2 domain of Nrf2 (Itoh
et al., 1999). Upon exposure to oxidative stress or electrophilic attack,
Keap1 loses its ability to repress Nrf2, allowing Nrf2 to escape
proteasomal degradation (Kobayashi et al., 2006). Nrf2 then trans-
locates to the nucleus and transcriptionally activates a battery of
cytoprotective genes.
We have recently reported that the ‘ETGE’ motif in the Neh2
domain of Nrf2 binds to Keap1 at the bottom region of the  -
propeller domain (also called the Kelch domain) (Padmanabhan et
al., 2006). As the other conserved ‘DLG’ motif in the Neh2 domain is
also functionally important for association with Keap1, we have
attempted to determine the C-terminal region of mouse Keap1,
containing the  -propeller domain (hereafter Keap1-DC; amino acid
residues 309–624), complexed with a 15-mer peptide containing the
DLG motif. We report here the preliminary crystal structure analysis
of the Keap1-DC complex with the DLG motif containing peptide at
1.9 A ˚ resolution.2. Materials and methods
2.1. Crystallization and data collection
The mouse Keap1-DC domain was expressed in Escherichia coli
and puriﬁed as previously described (Padmanabhan et al., 2005). The
crystals for the Keap1-DC complex were obtained by the co-crys-
tallization method. The DLG motif containing peptide (
22ILWRQ-
DIDLGVSREV
36, mouse Nrf2), purchased from Promega, was
mixed with Keap1-DC (4 mg ml
 1) (10:1 molar ratio) and incubated
at 277 K for about one day before setting up the crystallization
experiment. The co-crystals were obtained in a drop containing 0.8 M
lithium sulfate, 0.5 M ammonium sulfate and 0.1 M sodium citrate,
pH 5.2, at 293 K. Complete diffraction data were collected under
cryogenic conditions, using a Rigaku RA-Micro7 Cu K  rotating-
anode X-ray generator, operated at 40 kVand 20 mA and equipped
with a Rigaku RAXIS IV
++ imaging-plate area detector and an X-
stream low-temperature system. The diffraction data were indexed
and processed using HKL2000 (Otwinowski & Minor, 1997). The
results of the data reduction statistics are given in Table 1.
2.2. Structure determination and refinement
The structure of the Keap1-DC complex was determined by the
molecular replacement method, using the apo-form of Keap1-DC
structure (Padmanabhan et al., 2006) as a search model and the
program Molrep from the CCP4 suite (Collaborative Computational
Project, Number 4, 1994). It gave a distinct peak with an R factor and
correlation coefﬁcient of 0.363 and 0.690, respectively, at a resolution
between 20 A ˚ and 3.0 A ˚ . The model was reﬁned using CNS (Brunger
et al., 1998), and several rounds of manual ﬁtting and re-ﬁtting were
carried out using the program O (Jones et al., 1991), with careful
inspection of the 2Fo   Fc, Fo   Fc and omit electron density maps.
During the ﬁnal stage of reﬁnement, Refmac5 (Murshudov et al.,
1997), which is incorporated into the CCP4 suite, was used for
reﬁnement of the structure. The current reﬁned model consists of 301
residues, seven SO4 ions and 307 water molecules, with ﬁnal Rwork and
Rfree values of 17.2% and 21.1%, respectively, at a resolution of 1.9 A ˚ .
In Keap1-DC the electron density for the ﬁrst 15 residues at the N-
terminus and the last 11 residues at the C-terminus, and in the
peptide, residues from 22–23 and 30–36 were absent. A Ramachan-
dran analysis using the program PROCHECK (Laskowski et al.,
1993) showed that 224 residues (90%) were in the most favoured
region, 24 residues (9%) were in the additionally allowed region, one
residue (0.5%) was in the generously allowed region, and one residue
(0.5%) was in the disallowed region. The reﬁnement statistics are
summarized in Table 1. The atomic coordinates for the mouse Keap1-
DC–Neh2 peptide complex have been deposited in the Protein Data
Bank under the accession number 2DYH.
3. Results and discussion
3.1. Overall structure of the Keap1-DC–DLG peptide complex
The structure of this complex was solved by the molecular repla-
cement method using the apo-form of the Keap1-DC structure
(Padmanabhan et al., 2006) as a model at 2.5 A ˚ resolution, and
reﬁned to 1.9 A ˚ resolution. The Keap1-DC structure possesses a  -
propeller domain containing six blades, with sixfold pseudo symmetry
(Fig. 1). Each blade is a twisted  -sheet formed by four antiparallel  -
strands ( 1– 4). As found in other  -propeller domains, the  -strand
( 1) in the C-terminal region interacts with the  -strand ( 2) of the
N-terminal region (Fig. 1a); thereby the closure of this disc-like
molecule is achieved by ‘3 + 1’ division strands derived from N- and
C-termini (‘velcro’ closure or ‘molecular clasp’) (Neer & Smith,
1996). The Keap1-DC structure in the present complex is essentially
similar to that of the apo-form of Keap1-DC (Padmanabhan et al.,
2006) (root mean square deviation of 0.2 A ˚ for main-chain atoms).
The difference Fourier map unambiguously showed the electron
density at the peptide bound region. Although we used a peptide that
was 15 amino acids long for co-crystallization, from Ile22 to Val36, the
electron density was visible only for six amino acids, from Trp24 to
Asp29. The Trp24 and Ile28 residues were truncated to Ala as the
electron densities of the side-chains were absent. Since the electron
density of the side-chain atoms after C
  was not visible in Arg25
either, these atoms were not included in reﬁnement of the structure.
The ﬁnal Rwork and Rfree values were 17.2% and 21.1%, respectively,
for the 301 residues, seven sulfate ions and 307 water molecules,
reﬁned to a resolution of 1.9 A ˚ (Table 1).
The DLG peptide binds to Keap1-DC at the bottom side of the six-
bladed  -propeller (Fig. 1). The bottom region of the  -propeller
domain is highly basic and mainly occupied by arginine residues
(Fig. 2). In the interface region the peptide is surrounded by Tyr334,
Asn382, Arg483, Tyr525, Tyr572, Phe577, Arg415, Ser508, Gly509,
Ser555, Ala556, Ser602 and Gly603 of Keap1. The DLG peptide
appears to be positioned close to the fourth, ﬁfth and sixth blades of
the Kelch domain; however, the peptide interacts with residues from
almost all of the six blades.
The DLG peptide possesses a tight four-residue  -hairpin
conformation comprising the residues Arg25, Gln26, Asp27, Ile28
and Asp29 (Fig. 2). The structure of this peptide is stabilized by two
intramolecular hydrogen bonds: between Arg25 and Ile28, and Trp24
and Asp29. The formation of such a  -hairpin conformation in the
peptide allows the residues of the DLG motif to interact substantially
with the Keap1-DC amino acid residues.
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Table 1
Summary of data collection and reﬁnement statistics for the Keap1-DC–Neh2
peptide complex.
Data collection
Source RAXIS IV
++
Wavelength (A ˚ ) 1.5418
Space group P61
Unit cell (A ˚ ) a = b = 103.13, c = 56.14,   = 120 
Resolution (A ˚ ) 20.0–1.9
Completeness (%)† 98.2 (88.0)
Redundancy 8.6 (3.6)
Rmerge (%)‡ 8.6 (39.8)
Reﬁnement statistics
No. of complex molecules in a.u. 1
Resolution limit (A ˚ ) 20.0–1.9
  cutoff (F)0
No. of reﬂections 25143
Rwork/Rfree (%)§} 17.2/21.1
No. of protein residues 295
No. of peptide residues 6
No. of SO4 ions 7
No. of water molecules 307
Average B-factor (A ˚ 2)
Protein 32.5
Water 45.5
r.m.s. deviations
Bond lengths (A ˚ ) 0.016
Bond angles ( ) 1.55
† Numbers in parentheses are values in the highest resolution shell (1.95–
1.90 A ˚ ). ‡ Rmerge = hi|I(h)i  h I(h)i|/hiI(h)i, where I(h) is the observed intensity
of reﬂection h, hI(h)i is the mean intensity of reﬂection h over all measurements of I(h),
h is the sum over all reﬂections and i is the sum over i measurements of reﬂection
h.§ Rwork = ||Fobs|   |Fcalc||/|Fobs|. } Rfree was calculated with 5% of data omitted
from the reﬁnement.The Keap1-DC–DLG peptide complex generates eight potential
intermolecular electrostatic interactions between the peptide and the
 -propeller domain. Gln26 of Neh2 is a conserved residue within the
CNC protein family (Katoh et al., 2005) and has signiﬁcant inter-
molecular interactions with Ser508, Arg415, Arg483 and Ser555 of
Keap1-DC (Fig. 2). For instance, the side-chain of Gln26 is wedged
between Arg415 and Arg483. Furthermore, the O
"1 atom of Gln26
contributes a hydrogen bond and a salt bridge to Ser508 and Arg415,
respectively, while the N
"2 atom of Gln26 interacts electrostatically
with Arg483. In addition to these side-chain interactions, the main-
chain carbonyl group of Gln26 is hydrogen bonded to the side-chain
of Ser555.
Asp27 of the DLG motif interacts with multiple residues, such as
Ser602, Gly603 and Arg415, of Keap1 (Fig. 2). On the other hand, the
side-chain of the next residue, Ile28, which adopts a left-handed
helical conformation, was absent in the structure. However, this
residue is nicely positioned in a hydrophobic pocket produced by
Tyr572 and Phe577. Moreover, Asp29, the last residue visible in the
electron density map of the DLG peptide, contributes to an elec-
trostatic interaction with Asn382 of Keap1.
3.2. Comparison with Keap1-DC–ETGE peptide complex structure
We have recently reported the structure of Keap1-DC complexed
with Nrf2 peptide containing the ETGE motif (Padmanabhan et al.,
2006). Comparison of the Keap1-DC–DLG peptide complex with the
Keap1-DC–ETGE peptide complex revealed that both DLG and
ETGE fragments interact with Keap1 in a similar manner, by binding
through the bottom region of the  -propeller structure (Fig. 3).
Superimposition of the structures of these two complexes over the
main-chain atoms of Keap1-DC revealed that the overall structure of
Keap1-DC in these two complexes is almost the same (0.23 A ˚ r.m.s.
deviation). However, a small variation was observed in the loop
connecting strands  2 and  3 of the second blade of the Kelch
domain. At the binding region, the side-chains of the Keap1-DC
residues possess a very similar conformation within the two
complexes, except for Arg415, Arg483 and Asn382 (not shown).
Although both peptide structures are quite ﬂexible, they adopt a
similar kind of tight  -turn conformation and also orientate in
essentially the same manner with respect to the Keap1-DC structure
(Fig. 3). However, the ETGE peptide possesses a comparatively
higher number of electrostatic interactions with Keap1-DC than the
DLG peptide: approximately 13 in the ETGE peptide complex versus
eight in the DLG peptide complex. Furthermore, the ETGE peptide
is signiﬁcantly embedded into the Keap1-DC binding cleft compared
with the DLG peptide. For instance, the side-chain of Glu79 in the
ETGE is well buried in the pocket, whereas the equivalent residue in
the DLG, Gln26, is partially buried (Fig. 3). These results therefore
suggest that, although the bottom region of Keap1-DC is common for
the ETGE and DLG motif interactions, their binding strengths are
comparatively different with respect to each other. Our extensive
point mutation studies for the ETGE and DLG motifs interactions
with Keap1 suggested that the ETGE motif has a higher afﬁnity than
the DLG motif (Tong, Kobayashi et al., 2006; Tong et al., 2007).
Data obtained to date suggest that the Keap1 homodimer binds to
one Nrf2 by means of two recognition sites, the DLG and ETGE
motifs in the Neh2 domain of Nrf2. The Keap1 protein exists as a
homodimer in solution (Tong, Kobayashi et al., 2006). The dual
recognition sites have physiological relevance, since it has been
shown that mutation or deletion of the DLG motif hampers both
Keap1-dependent ubiquitination and proteasomal degradation
(McMahon et al., 2004; Katoh et al., 2005). Based on the structures of
Keap1-DC complexes and functional studies, we have recently
proposed a two-site substrate recognition hinge-latch model of the
Keap1–Nrf2 system for regulatory mechanism of Nrf2 activation/
depression (Tong, Katoh et al., 2006; Tong et al., 2007).
In summary, the present Keap1-DC–DLG peptide complex
structure revealed that Keap1 shares the common binding site for
both the DLG and ETGE motifs of Nrf2 interactions but with
different binding strengths. However, additional structure studies on
the complete Neh2 of Nrf2 with Keap1-DC are necessary to further
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Figure 2
Close-up view of the peptide binding region. (a) Part of the reﬁned DLG peptide
showing Gln26 and Asp27. The ﬁnal electron density 2mFo   DFc map is contoured
at 1.0 .( b) The interacting residues of the complex are shown by sticks, hydrogen
bonds by dashed lines, and a water molecule by a ball.
Figure 3
Superimposition of the DLG peptide complex with the ETGE peptide complex.
Electrostatic surface potential of mKeap1-DC in the mKeap1-DC peptide
complexes. Surface acidic, basic and neutral residues are shown in red, blue and
white, respectively. The protein-bound ETGE (yellow) and DLG (slate) peptides
are shown by sticks.
Figure 1
The overall tertiary structure of mouse Keap1-DC complexed with the DLG
peptide. Ribbon model of the tertiary structure of the mKeap1-DC  -propeller
domain (blue to red) and the DLG peptide (slate). (a) Bottom view. (b) Side view.
The ﬁgure was generated using PyMOL (http://www.pymol.org/).understand the molecular mechanism of the Nrf2 transcription factor
which plays an important role in environmental stress.
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